A verification of the application of the non-derivatized mass spectrometry method in newborns screening of metabolic disorders

It is required that the clinical screening of metabolic disorders in newborns meet International Organization for Standardization 15189-2012 approval. The new tandem mass spectrometry (MS/MS) based screening system and its companion reagent should be independently authenticated before their implemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yulan, Chen, Yao, Qiu, Xiaolong, Chen, Weifen, Lin, Qingying, Zeng, Yinglin, Zhao, Hong, Zhu, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531236/
https://www.ncbi.nlm.nih.gov/pubmed/31083189
http://dx.doi.org/10.1097/MD.0000000000015500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531236/
https://www.ncbi.nlm.nih.gov/pubmed/31083189
http://dx.doi.org/10.1097/MD.0000000000015500

Ejemplares similares